Brief: Humacyte Q3 Operating Expenses USD 25.143 Million
12/11/2025 12:00
Nov 12 (Reuters) - Humacyte Q3 basic EPS USD -0.11. Q3 operating income USD -24.39 million vs. IBES estimate USD -24.3 million Q3 net income USD -17.51 million vs. IBES estimate USD -25.1 million
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary